What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Biochemistry, Molecular biology, Concanavalin A, Lectin and Peptide sequence.
His studies link Spliceosome with Biochemistry.
In the subject of general Molecular biology, his work in Cycloheximide and Cleavage is often linked to 3T3 cells, thereby combining diverse domains of study.
His Concanavalin A study integrates concerns from other disciplines, such as Molecule, Receptor, Protein subunit and Binding site.
His work carried out in the field of Lectin brings together such families of science as Cytoplasm and Cell biology.
His work on Galectin 4 and Galectin-8 as part of general Galectin research is frequently linked to Beta-galactoside, bridging the gap between disciplines.
His most cited work include:
- Galectins: a family of animal beta-galactoside-binding lectins. (986 citations)
- Intracellular functions of galectins (535 citations)
- The Covalent and Three-Dimensional Structure of Concanavalin A (441 citations)
What are the main themes of his work throughout his whole career to date?
Biochemistry, Molecular biology, Cell biology, Lectin and Concanavalin A are his primary areas of study.
His work on Peptide sequence, Affinity chromatography, Galectin and Protein splicing as part of his general Biochemistry study is frequently connected to Bradyrhizobium japonicum, thereby bridging the divide between different branches of science.
His Molecular biology research includes elements of Immunofluorescence, Fibroblast, Messenger RNA and Monoclonal antibody.
His research integrates issues of Cell and Cell growth in his study of Cell biology.
John L. Wang has researched Lectin in several fields, including Agglutination, Cell membrane, Carbohydrate and Rhizobium.
As part of one scientific family, he deals mainly with the area of Concanavalin A, narrowing it down to issues related to the Cell surface receptor, and often Wheat germ agglutinin.
He most often published in these fields:
- Biochemistry (50.00%)
- Molecular biology (33.33%)
- Cell biology (25.00%)
What were the highlights of his more recent work (between 2007-2020)?
- Biochemistry (50.00%)
- Cell biology (25.00%)
- Galectin (11.67%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Biochemistry, Cell biology, Galectin, Spliceosome and Protein splicing.
John L. Wang undertakes interdisciplinary study in the fields of Biochemistry and Cancer cell through his research.
John L. Wang is studying Cytoplasm, which is a component of Cell biology.
His Cytoplasm study incorporates themes from Galectin-1 and Pre-mRNA splicing.
His study in Galectin is interdisciplinary in nature, drawing from both Biophysics and Alternative splicing.
His Spliceosome research is multidisciplinary, incorporating perspectives in Exonic splicing enhancer and Molecular biology.
Between 2007 and 2020, his most popular works were:
- AprilTag 2: Efficient and robust fiducial detection (189 citations)
- Dynamics of galectin-3 in the nucleus and cytoplasm. (110 citations)
- SR proteins and galectins: what's in a name? (36 citations)
In his most recent research, the most cited papers focused on:
John L. Wang mostly deals with Protein splicing, Spliceosome, Biochemistry, Molecular biology and Heterogeneous ribonucleoprotein particle.
He interconnects Exonic splicing enhancer and Galectin in the investigation of issues within Protein splicing.
His research related to Mutant, Transferrin and Alkaline phosphatase might be considered part of Biochemistry.
His studies in Heterogeneous ribonucleoprotein particle integrate themes in fields like Nuclear cap-binding protein complex, Importin, Nuclear transport, SR protein and Small nuclear ribonucleoprotein.
His Importin research is under the purview of Cell biology.
His works in Cytoplasm and Nuclear export signal are all subjects of inquiry into Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
